tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

TRAW Stock Latest News

Traws Pharma Highlights Positive Ratutrelvir Phase 2 COVID-19 Data
Company AnnouncementsTraws Pharma Highlights Positive Ratutrelvir Phase 2 COVID-19 Data
18d ago
8K
TRAW
Traws Pharma completes clinical analysis of Phase 2 study of ratutrelvir
PremiumThe Fly
Traws Pharma completes clinical analysis of Phase 2 study of ratutrelvir
19d ago
TRAW
Traws Pharma initiated with a Buy at Ladenburg
PremiumThe Fly
Traws Pharma initiated with a Buy at Ladenburg
1M ago
TRAW
Traws Pharma Completes Phase 2 Enrollment for COVID Candidate
PremiumCompany Announcements
Traws Pharma Completes Phase 2 Enrollment for COVID Candidate
1M ago
8K
TRAW
Traws Pharma completes enrollment in Phase 2 study of ratutrelvir
PremiumThe Fly
Traws Pharma completes enrollment in Phase 2 study of ratutrelvir
1M ago
TRAW
Traws Pharma’s TRX-100 Phase 1 Completion: A Quiet but Key Milestone for Investors
PremiumCompany AnnouncementsTraws Pharma’s TRX-100 Phase 1 Completion: A Quiet but Key Milestone for Investors
2M ago
TRAW
Traws Pharma advances flu and COVID-19 antiviral pipeline
Premium
Company Announcements
Traws Pharma advances flu and COVID-19 antiviral pipeline
2M ago
8K
TRAW
Traws Pharma files tivoxavir marboxil IND application with U.S. FDA
Premium
The Fly
Traws Pharma files tivoxavir marboxil IND application with U.S. FDA
2M ago
TRAW
Promising Phase 2 Results for Ratutrelvir Highlight Clinical and Market Differentiation in COVID-19 Treatment
PremiumRatings
Promising Phase 2 Results for Ratutrelvir Highlight Clinical and Market Differentiation in COVID-19 Treatment
3M ago
TRAW
Traws Pharma Reports Positive Phase 2 Trial Results
PremiumCompany Announcements
Traws Pharma Reports Positive Phase 2 Trial Results
3M ago
8K
TRAW
Traws Pharma reports ‘positive’ interim data with ratutrelvir vs. paxlovid
PremiumThe Fly
Traws Pharma reports ‘positive’ interim data with ratutrelvir vs. paxlovid
3M ago
TRAW
Traws Pharma Approves Executive Stock Options
PremiumCompany Announcements
Traws Pharma Approves Executive Stock Options
3M ago
8K
TRAW
Traws Pharma initiated with a Buy at H.C. Wainwright
PremiumThe FlyTraws Pharma initiated with a Buy at H.C. Wainwright
3M ago
TRAW
Traws Pharma Holds Virtual Annual Meeting 2025
Premium
Company Announcements
Traws Pharma Holds Virtual Annual Meeting 2025
3M ago
8K
TRAW
Traws Pharma Reports Q3 2025 Progress and Cost Reductions
Premium
Company Announcements
Traws Pharma Reports Q3 2025 Progress and Cost Reductions
4M ago
TRAW
Traws Pharma Reports Q3 2025 Financial Results
PremiumCompany Announcements
Traws Pharma Reports Q3 2025 Financial Results
4M ago
8K
TRAW
Traws Pharma reports Q3 EPS (34c) vs ($1.49) last year
PremiumThe Fly
Traws Pharma reports Q3 EPS (34c) vs ($1.49) last year
4M ago
TRAW
Traws Pharma’s New COVID-19 Drug Trial: A Potential Game-Changer?
PremiumCompany Announcements
Traws Pharma’s New COVID-19 Drug Trial: A Potential Game-Changer?
4M ago
TRAW
Traws Pharma’s TRX-100 Study: A Potential Game-Changer in Pharmacokinetics
PremiumCompany Announcements
Traws Pharma’s TRX-100 Study: A Potential Game-Changer in Pharmacokinetics
4M ago
TRAW
Traws Pharma Approves Executive Stock Options Grant
PremiumCompany AnnouncementsTraws Pharma Approves Executive Stock Options Grant
5M ago
8K
TRAW
Traws Pharma Begins Phase 2 COVID-19 Treatment Study
Premium
Company Announcements
Traws Pharma Begins Phase 2 COVID-19 Treatment Study
5M ago
8K
TRAW
Traws Pharma doses first patient with ratutrelvir in Phase 2 COVID studies
Premium
The Fly
Traws Pharma doses first patient with ratutrelvir in Phase 2 COVID studies
5M ago
TRAW

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >